MVA-BN-HIV

BIOLOGICAL2 trials

Sponsors

Boris Juelg, MD PhD, Henry M. Jackson Foundation for the Advancement of Military Medicine

Conditions

Acquired Immunodeficiency SyndromeHIVHIV-1-infectionImmunologic Deficiency Syndrome, AcquiredRetroviridae InfectionsSexually Transmitted Diseases, Viral

Phase 1

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Active, not recruitingNCT04983030

Boris Juelg, MD PhDAcquired Immunodeficiency Syndrome, HIV, Immunologic Deficiency Syndrome, Acquired +2

Start: 2022-04-01End: 2026-04-30Target: 36Updated: 2026-01-12

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission

WithdrawnNCT05769569

Henry M. Jackson Foundation for the Advancement of Military MedicineHIV-1-infection

Start: 2023-09-01End: 2025-07-01Updated: 2024-05-03

Related Papers

Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection

JCI Insight2025-02-235 citations